Received Aug 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC21 | PNEUMO (CAPVAXIVE) | MERCK & CO. INC. | UNK | Z004302 | OT |
numbness on her arm; rash at the injection site; soreness; This spontaneous report was received from a pharmacist and refers to a 62-year-old female patient. The patient's medical history, drug reactions and concomitant therapies were reported as none. The patient's concurrent conditions were not reported. On 15-Jul-2025, the patient received Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) (lot #z004302, expiration date: 04-Sep-2026, 1 dosage form (1 dose), formulation and strength were not reported) via intramuscular for prophylaxis. On 15-Jul-2025, on the first day of the vaccination, the patient experienced soreness. On 19-Jul-2025, on the fifth day of the vaccination, the patient developed rash at the injection site and numbness on her arm. She couldn't put pressure on her arm when she goes to sleep. No medical attention was sought. No treatment was given for the events. At the reporting time, the patient had not recovered from numbness on her arm, soreness and rash at the injection site. The causal relationships between all the events and Pneumococcal 21-valent Conjugate Vaccine (CAPVAXIVE) were not provided.
Comments: none